Image

Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'Ivoire

Testing newborns for early sickle cell care in Yopougon, Côte d'Ivoire.

Recruiting
6 years and younger
All
Phase 4
**Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'Ivoire** Sickle cell disease (SCD) is a serious blood disorder that you inherit from your parents. It affects the red blood cells, which carry oxygen in your body. This study is looking at a new way to test and care for babies with SCD in Côte d'Ivoire. The goal is to see if using a special test called Gazelle Multispectral and starting treatment early can help babies with SCD stay healthier. Key points: - The study will last 2.5 to 3.5 years and will compare new results with old data from the region. - Babies will be tested early, and if they have SCD, they will get special care including medicines and vaccines. - Parents will learn how to take care of their baby and when to seek medical help. Children aged 0-6 months can join if they're healthy and haven't had a blood transfusion in the last 90 days. Babies already diagnosed with SCD, in another study, or very sick can't join. The study hopes to improve care and save lives in the region.
Study details
    Sickle Cell Disease (SCD)

NCT07488520

Swiss Tropical & Public Health Institute

17 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.